254
Participants
Start Date
December 31, 2006
Primary Completion Date
December 31, 2009
Study Completion Date
August 31, 2010
Intraspinal Gabapentin
Surgical implantation of a drug infusion system with intrathecal (spinal) delivery of active drug (1 of 3 possible dose levels) or placebo (saline) for 22 days followed by 7 days of infusion at half dose level. Subjects may then continue in open-label treatment with study drug. Dosage in open-label may be adjusted to meet subject needs.
U B Neurosurgery, Inc., Buffalo
Lehigh Valley Hospital Center for Pain Management, Allentown
The Center for Clinical Research, Winston-Salem
Sarasota Pain Medicine Research, Sarasota
MAPS Applied Research Center, Edina
Mayo Clinic, Rochester
WK River Cities Clinical Research Center, Shreveport
Innovative Spine Care, Little Rock
Pinnacle Pain Medicine, Dallas
Axis Spine Care/Texas Spine & Joint, Tyler
Lifetree Clinical Research, Salt Lake City
Napa Pain Institute, Napa
Oregon Health & Science University, Neurosurgery Department, Portland
Pain Research of Oregon, LLC, Eugene
Lead Sponsor
MedtronicNeuro
INDUSTRY